Skip to main content

1 Result(s)

within Chunling Zeng Remove this filter

and

  1. Article

    Spectrum of activity of dasatinib against mutant KIT kinases associated with drug-sensitive and drug-resistant gastrointestinal stromal tumors

    The majority of GISTs express mutationally activated KIT. Imatinib and sunitinib are approved KIT-inhibiting therapies. Their efficacy is usually hampered by the acquired multiple secondary drug-resistance KIT mu...

    Chunling Zeng, Li Zhu, **aona Jia, Yuzhi Pang, Zhang Li, **ao**g Lu… in Gastric Cancer (2020)

    Download PDF (2520 KB) View Article